EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

First reported survival of anthrax meningoencephalitis in a low-incidence region: successful management with mNGS-guided combination therapy

Qiushuo Geng, Ye Wang, Yihao Fan, Nan Liu, Xiaoyun Zhao

Frontiers in Cellular and Infection Microbiology · 21.07.2026 · 16

DOI: 10.3389/fcimb.2026.1792720 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 21.07.2026. Verfasst von Qiushuo Geng und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Device, Shenyang Pharmaceutical University, Benxi, China. Hauptthemen laut MEDLINE: Meningoencephalitis, Anti-Bacterial Agents, Anthrax, Bacillus anthracis. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report a rare survival case of anthrax meningoencephalitis in a 56-year-old male from a low-incidence region. The patient presented with nasal discharge, fever, headache, and rapid onset of coma following the slaughter of a diseased cow. Physical examination revealed a characteristic ulcerative eschar on the right index finger, while laboratory investigations showed significant leukocytosis and hemorrhagic cerebrospinal fluid (CSF) characterized by elevated protein and decreased glucose levels. Although initial microscopy misidentified the pathogen as Bacillus cereus, metagenomic next−generation sequencing (mNGS) of the CSF confirmed Bacillus anthracis within 48 hours. This rapid molecular diagnosis enabled a timely switch to a CDC−recommended combination regimen, initially with quadruple therapy (penicillin G, ciprofloxacin, amikacin, and linezolid) followed by optimization to triple therapy (penicillin G, levofloxacin, and linezolid) during the ICU stay, ultimately leading to the patient’s full neurological recovery. This case underscores that the synergistic use of rapid mNGS−based diagnosis and appropriate combination therapy is critical for achieving survival in anthrax meningoencephalitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeningoencephalitisAnti-Bacterial AgentsAnthraxBacillus anthracisHumansMaleMiddle AgedDrug Therapy, CombinationCiprofloxacinHigh-Throughput Nucleotide SequencingAmikacinTreatment OutcomeAnimalsPenicillin GLinezolidLevofloxacinCerebrospinal Fluid

Stichwörter der Autor:innen

Bacillus anthracisMNGsanthrax meningoencephalitismetagenomic next-generation sequencingtriple antibiotic therapy

Substanzen

Anti-Bacterial AgentsCiprofloxacinAmikacinPenicillin GLinezolidLevofloxacin

Autor:innen und Institutionen

  • School of Medical Device, Shenyang Pharmaceutical University, Benxi, China.
  • School of Biomedical Engineering, Tsinghua Medicine, Tsinghua University, Beijing, China.
  • Department of Neurology, People's Hospital of Liaoning Province, Shenyang, China.
  • School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, China.

Zitieren

APA

Geng, Q., Wang, Y., Fan, Y., Liu, N., & Zhao, X. (2026). First reported survival of anthrax meningoencephalitis in a low-incidence region: successful management with mNGS-guided combination therapy. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1792720

Vancouver

Geng Q, Wang Y, Fan Y, Liu N, Zhao X. First reported survival of anthrax meningoencephalitis in a low-incidence region: successful management with mNGS-guided combination therapy. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1792720

BibTeX
@article{Geng2026,
  author = {Geng, Qiushuo and Wang, Ye and Fan, Yihao and Liu, Nan and Zhao, Xiaoyun},
  title = {First reported survival of anthrax meningoencephalitis in a low-incidence region: successful management with mNGS-guided combination therapy},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1792720}
}
Kostenlos starten →